Trust Department MB Financial Bank N A cut its stake in Cerner Co. (NASDAQ:CERN) by 4.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 134,739 shares of the company’s stock after selling 6,832 shares during the quarter. Trust Department MB Financial Bank N A’s holdings in Cerner were worth $9,080,000 at the end of the most recent quarter.
Other hedge funds also recently made changes to their positions in the company. Advisory Services Network LLC increased its stake in shares of Cerner by 4.4% in the 2nd quarter. Advisory Services Network LLC now owns 1,648 shares of the company’s stock valued at $110,000 after acquiring an additional 70 shares during the last quarter. Acrospire Investment Management LLC increased its stake in shares of Cerner by 100.0% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,800 shares of the company’s stock valued at $120,000 after acquiring an additional 900 shares during the last quarter. Fuller & Thaler Asset Management Inc. bought a new stake in shares of Cerner in the 3rd quarter valued at about $121,000. Steward Partners Investment Advisory LLC bought a new stake in Cerner during the 3rd quarter worth approximately $128,000. Finally, Sun Life Financial INC increased its stake in Cerner by 23,700.0% during the 2nd quarter. Sun Life Financial INC now owns 2,142 shares of the company’s stock worth $142,000 after purchasing an additional 2,133 shares in the last quarter. 81.83% of the stock is owned by institutional investors.
A number of analysts recently issued reports on CERN shares. Cantor Fitzgerald reissued a “buy” rating and set a $77.00 target price on shares of Cerner in a research note on Tuesday, October 10th. Zacks Investment Research cut Cerner from a “buy” rating to a “hold” rating in a research note on Thursday, January 4th. KeyCorp reissued a “buy” rating and set a $76.00 target price on shares of Cerner in a research note on Friday, September 22nd. SunTrust Banks reissued a “buy” rating and set a $79.00 target price on shares of Cerner in a research note on Thursday, October 19th. Finally, Robert W. Baird raised Cerner from a “neutral” rating to an “outperform” rating and increased their target price for the stock from $67.00 to $76.00 in a research note on Tuesday, October 31st. Sixteen research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Cerner currently has a consensus rating of “Hold” and a consensus price target of $69.83.
Shares of Cerner Co. (NASDAQ CERN) traded up $0.26 on Tuesday, hitting $72.90. 1,750,700 shares of the stock traded hands, compared to its average volume of 1,539,311. The company has a market cap of $24,230.00, a PE ratio of 36.27, a P/E/G ratio of 2.17 and a beta of 0.94. Cerner Co. has a one year low of $50.33 and a one year high of $73.86. The company has a quick ratio of 2.75, a current ratio of 2.77 and a debt-to-equity ratio of 0.11.
Cerner (NASDAQ:CERN) last issued its quarterly earnings results on Thursday, October 26th. The company reported $0.61 earnings per share for the quarter, missing the consensus estimate of $0.62 by ($0.01). The business had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.29 billion. Cerner had a return on equity of 18.03% and a net margin of 13.37%. Cerner’s revenue was up 7.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.59 earnings per share. equities research analysts forecast that Cerner Co. will post 2.24 EPS for the current year.
In other news, Chairman Clifford W. Illig sold 4,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 7th. The shares were sold at an average price of $65.96, for a total transaction of $263,840.00. Following the completion of the transaction, the chairman now directly owns 1,229,719 shares of the company’s stock, valued at approximately $81,112,265.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Zane M. Burke sold 50,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 13th. The stock was sold at an average price of $70.00, for a total transaction of $3,500,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 788,000 shares of company stock valued at $52,190,800 over the last ninety days. Company insiders own 13.11% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Cerner Co. (CERN) Stake Lowered by Trust Department MB Financial Bank N A” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another publication, it was stolen and reposted in violation of US and international trademark & copyright laws. The correct version of this article can be viewed at https://www.dispatchtribunal.com/2018/01/16/cerner-co-cern-stake-lowered-by-trust-department-mb-financial-bank-n-a.html.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.